These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1053 related articles for article (PubMed ID: 29516506)
1. IFN-γ-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling. Gao Y; Yang J; Cai Y; Fu S; Zhang N; Fu X; Li L Int J Cancer; 2018 Aug; 143(4):931-943. PubMed ID: 29516506 [TBL] [Abstract][Full Text] [Related]
2. PD-L1 induced by IFN-γ from tumor-associated macrophages via the JAK/STAT3 and PI3K/AKT signaling pathways promoted progression of lung cancer. Zhang X; Zeng Y; Qu Q; Zhu J; Liu Z; Ning W; Zeng H; Zhang N; Du W; Chen C; Huang JA Int J Clin Oncol; 2017 Dec; 22(6):1026-1033. PubMed ID: 28748356 [TBL] [Abstract][Full Text] [Related]
3. A Novel Kinase Inhibitor AX-0085 Inhibits Interferon-γ-Mediated Induction of PD-L1 Expression and Promotes Immune Reaction to Lung Adenocarcinoma Cells. Kim J; Jang H; Lee GJ; Hur Y; Keum J; Jo JK; Yun SE; Park SJ; Park YJ; Choi MJ; Kim KS; Kim J Cells; 2021 Dec; 11(1):. PubMed ID: 35011581 [TBL] [Abstract][Full Text] [Related]
4. Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer. Teramoto K; Igarashi T; Kataoka Y; Ishida M; Hanaoka J; Sumimoto H; Daigo Y Lung Cancer; 2019 Nov; 137():56-63. PubMed ID: 31546072 [TBL] [Abstract][Full Text] [Related]
5. Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth. Rawangkan A; Wongsirisin P; Namiki K; Iida K; Kobayashi Y; Shimizu Y; Fujiki H; Suganuma M Molecules; 2018 Aug; 23(8):. PubMed ID: 30126206 [TBL] [Abstract][Full Text] [Related]
6. PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer. Yu W; Hua Y; Qiu H; Hao J; Zou K; Li Z; Hu S; Guo P; Chen M; Sui S; Xiong Y; Li F; Lu J; Guo W; Luo G; Deng W Cell Death Dis; 2020 Jul; 11(7):506. PubMed ID: 32632098 [TBL] [Abstract][Full Text] [Related]
7. TGFβ Antagonizes IFNγ-Mediated Adaptive Immune Evasion via Activation of the AKT-Smad3-SHP1 Axis in Lung Adenocarcinoma. Ye F; Cai Z; Wang B; Zeng C; Xi Y; Hu S; Qu R; Yuan Z; Yue J; Tian Y; Wang X; Fu X; Li L Cancer Res; 2023 Jul; 83(13):2262-2277. PubMed ID: 37145144 [TBL] [Abstract][Full Text] [Related]
8. mRNA expression of programmed cell death ligand 1 and components of the phosphatidylinositol 3-kinase/AKT/phosphatase and tensin homolog pathway in epidermal growth factor receptor mutation-positive lung adenocarcinoma. Han K; Zhang Y J Cancer Res Ther; 2019; 15(4):914-920. PubMed ID: 31436252 [TBL] [Abstract][Full Text] [Related]
9. Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells. Homma S; Hayashi K; Yoshida K; Sagawa Y; Kamata Y; Ito M Int Immunopharmacol; 2018 Jan; 54():39-45. PubMed ID: 29100036 [TBL] [Abstract][Full Text] [Related]
10. miR-375 inhibits IFN-γ-induced programmed death 1 ligand 1 surface expression in head and neck squamous cell carcinoma cells by blocking JAK2/STAT1 signaling. Wu Q; Zhao Y; Sun Y; Yan X; Wang P Oncol Rep; 2018 Mar; 39(3):1461-1468. PubMed ID: 29328389 [TBL] [Abstract][Full Text] [Related]
11. IL-27 mediates HLA class I up-regulation, which can be inhibited by the IL-6 pathway, in HLA-deficient Small Cell Lung Cancer cells. Carbotti G; Nikpoor AR; Vacca P; Gangemi R; Giordano C; Campelli F; Ferrini S; Fabbi M J Exp Clin Cancer Res; 2017 Oct; 36(1):140. PubMed ID: 29020964 [TBL] [Abstract][Full Text] [Related]
12. PD-1/PD-L1 blockade rescue exhausted CD8+ T cells in gastrointestinal stromal tumours via the PI3K/Akt/mTOR signalling pathway. Zhao R; Song Y; Wang Y; Huang Y; Li Z; Cui Y; Yi M; Xia L; Zhuang W; Wu X; Zhou Y Cell Prolif; 2019 May; 52(3):e12571. PubMed ID: 30714229 [TBL] [Abstract][Full Text] [Related]
13. Morphine-3-glucuronide upregulates PD-L1 expression Wang K; Wang J; Liu T; Yu W; Dong N; Zhang C; Xia W; Wei F; Yang L; Ren X Cancer Biol Med; 2021 Feb; 18(1):155-171. PubMed ID: 33628591 [TBL] [Abstract][Full Text] [Related]
14. IL-10 suppresses IFN-γ-mediated signaling in lung adenocarcinoma. Gao Y; Lu J; Zeng C; Yang J; Huang B; Zhang N; Li L; Fu X Clin Exp Med; 2020 Aug; 20(3):449-459. PubMed ID: 32306136 [TBL] [Abstract][Full Text] [Related]
15. Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells. Yuan LW; Jiang XM; Xu YL; Huang MY; Chen YC; Yu WB; Su MX; Ye ZH; Chen X; Wang Y; Lu JJ Phytomedicine; 2021 Jan; 80():153394. PubMed ID: 33130472 [TBL] [Abstract][Full Text] [Related]
16. CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer. Zhang C; Li Z; Xu L; Che X; Wen T; Fan Y; Li C; Wang S; Cheng Y; Wang X; Qu X; Liu Y BMC Cancer; 2018 Apr; 18(1):462. PubMed ID: 29690901 [TBL] [Abstract][Full Text] [Related]
17. MYC inhibition increases PD-L1 expression induced by IFN-γ in hepatocellular carcinoma cells. Zou J; Zhuang M; Yu X; Li N; Mao R; Wang Z; Wang J; Wang X; Zhou H; Zhang L; Shi Y Mol Immunol; 2018 Sep; 101():203-209. PubMed ID: 30007230 [TBL] [Abstract][Full Text] [Related]
18. CD137 ligand feedback upregulates PD-L1 expression on lung cancer via T cell production of IFN-γ. Wang H; Yan Z; Hao J; Yang B; Wang J; Yi L; Wang X; Li S; Zhang H; Zhang S Thorac Cancer; 2019 Dec; 10(12):2225-2235. PubMed ID: 31625289 [TBL] [Abstract][Full Text] [Related]
19. Transcription Factor ETV4 Activates AURKA to Promote PD-L1 Expression and Mediate Immune Escape in Lung Adenocarcinoma. Yang P; He S; Ye L; Weng H Int Arch Allergy Immunol; 2024; 185(9):910-920. PubMed ID: 38781935 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and prognostic significance of programmed cell death ligand-1 expression in lung adenocarcinoma and its relationship with p53 status. Cha YJ; Kim HR; Lee CY; Cho BC; Shim HS Lung Cancer; 2016 Jul; 97():73-80. PubMed ID: 27237031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]